A Bayesian parametric approach to handle missing longitudinal outcome data in trial‐based health economic evaluations

Trial-based economic evaluations are typically performed on cross-sectional variables, derived from the responses for only the completers in the study, using methods that ignore the complexities of utility and cost data (e.g. skewness and spikes). We present an alternative and more efficient Bayesian parametric approach to handle missing longitudinal outcomes in economic evaluations, while accounting for the complexities of the data. We specify a flexible parametric model for the observed data and partially identify the distribution of the missing data with partial identifying restrictions and sensitivity parameters. We explore alternative nonignorable scenarios through different priors for the sensitivity parameters, calibrated on the observed data. Our approach is motivated by, and applied to, data from a trial assessing the cost-effectiveness of a new treatment for intellectual disability and challenging behaviour.

[1]  Roderick J. A. Little,et al.  A Class of Pattern-Mixture Models for Normal Incomplete Data , 1994 .

[2]  Andrea Manca,et al.  Regression Estimators for Generic Health-Related Quality of Life and Quality-Adjusted Life Years , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[3]  Andrew H. Briggs,et al.  Handling Uncertainty in Cost-Effectiveness Models , 2000, PharmacoEconomics.

[4]  Gianluca Baio,et al.  Bayesian Methods in Health Economics , 2012 .

[5]  M. A. Best.  Bayesian Approaches to Clinical Trials and Health‐Care Evaluation , 2005 .

[6]  Sylvia Richardson,et al.  Two-pronged Strategy for Using DIC to Compare Selection Models with Non-Ignorable Missing Responses , 2012 .

[7]  Simon G Thompson,et al.  Accounting for uncertainty in health economic decision models by using model averaging , 2009, Journal of the Royal Statistical Society. Series A,.

[8]  Gianluca Baio,et al.  A full Bayesian model to handle structural ones and missingness in economic evaluations from individual‐level data , 2018, Statistics in medicine.

[9]  D. O. Scharfstein.  Adjusting for nonignorable dropout using semiparametric nonresponse models (with discussion) , 1999 .

[10]  J W Hogan,et al.  Reparameterizing the Pattern Mixture Model for Sensitivity Analyses Under Informative Dropout , 2000, Biometrics.

[11]  M. Kenward,et al.  The analysis of longitudinal ordinal data with nonrandom drop-out , 1997 .

[12]  Simon G Thompson,et al.  Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations. , 2005, Health economics.

[13]  J T Gaskins,et al.  Bayesian Methods for Nonignorable Dropout in Joint Models in Smoking Cessation Studies , 2016, Journal of the American Statistical Association.

[14]  R. Omar,et al.  Positive behaviour support training for staff for treating challenging behaviour in people with intellectual disabilities: a cluster RCT. , 2018, Health technology assessment.

[15]  G. Baio,et al.  Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations , 2017, PharmacoEconomics - Open.

[16]  M. Drummond,et al.  Whither trial-based economic evaluation for health care decision making? , 2006, Health economics.

[17]  Andrew Gelman,et al.  Handbook of Markov Chain Monte Carlo , 2011 .

[18]  M J Al,et al.  Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.

[19]  James R Carpenter,et al.  Multilevel models for cost-effectiveness analyses that use cluster randomised trial data: An approach to model choice , 2016, Statistical methods in medical research.

[20]  Roderick J. A. Little,et al.  Statistical Analysis with Missing Data , 1988 .

[21]  Rosalba Radice,et al.  Copula selection models for non‐Gaussian outcomes that are missing not at random , 2018, Statistics in medicine.

[22]  Geert Molenberghs,et al.  Ignorance and uncertainty regions as inferential tools in a sensitivity analysis , 2006 .

[23]  G. Baio.  Bayesian Models for Cost-Effectiveness Analysis in the Presence of Structural Zero Costs. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[24]  Antonio R. Linero,et al.  Bayesian Approaches for Missing Not at Random Outcome Data: The Role of Identifying Restrictions. , 2018, Statistical science : a review journal of the Institute of Mathematical Statistics.

[25]  Dandan Xu,et al.  A note on posterior predictive checks to assess model fit for incomplete data , 2016, Statistics in medicine.

[26]  Bas Groot Koerkamp,et al.  Limitations of Acceptability Curves for Presenting Uncertainty in Cost-Effectiveness Analysis , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[27]  Richard Grieve,et al.  Developing Appropriate Methods for Cost-Effectiveness Analysis of Cluster Randomized Trials , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[28]  James R Carpenter,et al.  Missing data in trial‐based cost‐effectiveness analysis: An incomplete journey , 2018, Health economics.

[29]  James M. Robins,et al.  Adjusting for Nonignorable Drop-Out Using Semiparametric Nonresponse Models: Rejoinder , 1999 .

[30]  Michael J Daniels,et al.  A Flexible Bayesian Approach to Monotone Missing Data in Longitudinal Studies With Nonignorable Missingness With Application to an Acute Schizophrenia Clinical Trial , 2015, Journal of the American Statistical Association.

[31]  Gianluca Baio,et al.  Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: a Review with Future Guidelines , 2016, 1607.06447.

[32]  Simon G Thompson,et al.  How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions? , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[33]  A. Rotnitzky,et al.  Missing Data in Longitudinal Studies: Strategies for Bayesian Modeling and Sensitivity Analysis by DANIELS, M. J. and HOGAN, J. W , 2009 .

[34]  C. Robert,et al.  Deviance information criteria for missing data models , 2006 .

[35]  D. Spiegelhalter,et al.  Bayesian Approaches to Clinical Trials and Health-Care Evaluation: Spiegelhalter/Clinical Trials and Health-Care Evaluation , 2004 .

[36]  M. Sculpher,et al.  Decision Modelling for Health Economic Evaluation , 2006 .

[37]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[38]  Bradley P. Carlin,et al.  Bayesian measures of model complexity and fit , 2002 .

[39]  Roderick J. A. Little,et al.  Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data , 2002 .

[40]  C. Dirksen,et al.  How to Deal with Cost Differences at Baseline , 2012, PharmacoEconomics.

[41]  R. Willke,et al.  Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[42]  David B. Dunson,et al.  Bayesian Data Analysis , 2010 .

[43]  D. Spiegelhalter,et al.  Incorporation of uncertainty in health economic modelling studies , 2012, PharmacoEconomics.

[44]  M. Daniels,et al.  A Note on MAR, Identifying Restrictions, Model Comparison, and Sensitivity Analysis in Pattern Mixture Models with and without Covariates for Incomplete Data , 2011, Biometrics.

[45]  A O'Hagan,et al.  A framework for cost-effectiveness analysis from clinical trial data. , 2001, Health economics.

[46]  Nicola J Cooper,et al.  Use of Bayesian Markov Chain Monte Carlo Methods to Model Cost-of-Illness Data , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

[47]  M. Sculpher,et al.  Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. , 2005, Health economics.

[48]  Michael G. Kenward,et al.  Handling missing values in cost effectiveness analyses that use data from cluster randomized trials , 2012, 1206.6070.

[49]  W C Black,et al.  The CE Plane , 1990, Medical decision making : an international journal of the Society for Medical Decision Making.

[50]  S. Noble,et al.  Missing data in trial-based cost-effectiveness analysis: the current state of play. , 2012, Health economics.

[51]  Roger A. Sugden,et al.  Multiple Imputation for Nonresponse in Surveys , 1988 .